FDA Drug Shortage Database
Midazolam (Versed) shortage
The FDA Drug Shortage Database lists 12 of 27 midazolam presentations as limited or unavailable (updated October 6, 2026); the first entry was posted on April 2, 2020. 15 more presentations are on the list as available.
- Generic listed
- In shortage
- Boxed warning
- DEA Schedule IV
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 0.9% injection | 0 | 2 | 0 |
| 1mg/1ml injection | 2 | 6 | 0 |
| 2mg/2ml injection | 3 | 0 | 0 |
| 5mg/1ml injection | 3 | 5 | 0 |
| 5mg/5ml injection | 1 | 0 | 0 |
| 5mg/ml injection | 1 | 0 | 0 |
| 10mg/10ml injection | 1 | 0 | 0 |
| 10mg/2ml injection | 1 | 0 | 0 |
| 25mg/5ml injection | 0 | 1 | 0 |
| 50mg/10ml injection | 0 | 1 | 0 |
Which presentations are listed?
Limited or unavailable now (12)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02) | Hospira, Inc., a Pfizer Company | Current posted April 2, 2020, updated September 22, 2026 | Unavailable; Demand increase for the drug |
| Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20) | Fresenius Kabi USA, LLC | Current posted April 2, 2020, updated September 15, 2026 | Unavailable; Demand increase for the drug |
| Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-0001-25) | Hospira, Inc., a Pfizer Company | Current posted April 2, 2020, updated September 22, 2026 | Limited Availability; Demand increase for the drug |
| Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17) | Hospira, Inc., a Pfizer Company | Current posted April 2, 2020, updated September 22, 2026 | Limited Availability; Demand increase for the drug |
| Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05) | Hospira, Inc., a Pfizer Company | Current posted April 2, 2020, updated September 22, 2026 | Unavailable; Demand increase for the drug |
| Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01) | Hospira, Inc., a Pfizer Company | Current posted April 2, 2020, updated September 22, 2026 | Unavailable; Demand increase for the drug |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02) | Gland Pharma Limited | Current posted April 2, 2020, updated July 22, 2026 | Unavailable; Other |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10) | Fresenius Kabi USA, LLC | Current posted April 2, 2020, updated October 6, 2026 | Unavailable; Delay in shipping of the drug |
| Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05) | Hospira, Inc., a Pfizer Company | Current posted April 2, 2020, updated September 22, 2026 | Unavailable; Demand increase for the drug |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10) | Gland Pharma Limited | Current posted April 2, 2020, updated July 22, 2026 | Unavailable; Other |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10) | Fresenius Kabi USA, LLC | Current posted April 2, 2020, updated October 6, 2026 | Unavailable; Demand increase for the drug |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25) | Fresenius Kabi USA, LLC | Current posted April 2, 2020, updated October 6, 2026 | Unavailable; Demand increase for the drug |
Listed now, available (15)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10) | Hikma Pharmaceuticals USA, Inc. | Current posted April 2, 2020, updated September 18, 2026 | Available |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25) | Hikma Pharmaceuticals USA, Inc. | Current posted April 2, 2020, updated September 18, 2026 | Available |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01) | Hikma Pharmaceuticals USA, Inc. | Current posted April 2, 2020, updated September 18, 2026 | Available |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41) | Avet Pharmaceuticals, Inc. | Current posted April 2, 2020, updated October 5, 2026 | Available |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12) | Fresenius Kabi USA, LLC | Current posted April 2, 2020, updated October 6, 2026 | Available |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25) | Fresenius Kabi USA, LLC | Current posted April 2, 2020, updated October 6, 2026 | Available |
| Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03) | Hospira, Inc., a Pfizer Company | Current posted April 2, 2020, updated September 22, 2026 | Available |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10) | Hikma Pharmaceuticals USA, Inc. | Current posted April 2, 2020, updated September 18, 2026 | Available |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25) | Hikma Pharmaceuticals USA, Inc. | Current posted April 2, 2020, updated September 18, 2026 | Available |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-41) | Avet Pharmaceuticals, Inc. | Current posted April 2, 2020, updated October 5, 2026 | Available |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-42) | Avet Pharmaceuticals, Inc. | Current posted April 2, 2020, updated October 5, 2026 | Available |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02) | Fresenius Kabi USA, LLC | Current posted April 2, 2020, updated October 6, 2026 | Available |
| Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05) | Hospira, Inc., a Pfizer Company | Current posted April 2, 2020, updated September 22, 2026 | Available |
| Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10) | WG Critical Care | Current posted April 2, 2020, updated October 1, 2026 | Available |
| Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10) | WG Critical Care | Current posted April 2, 2020, updated October 1, 2026 | Available |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
What next?
- Every shortage now
- medicines by presentations in shortage